Prostate Cancer Clinical Trials in Baltimore

Showing 141-160 of 228 trials

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

NCT02981368

This study evaluates the safety and diagnostic performance of 18F-DCFPyL Injection in patients with at least high risk prostate cancer who are planned for radical prostatectomy with lymphadenectomy (Cohort A) or in patients with locally recurrent or metastatic disease willing to undergo biopsy (Cohort B). Cohort B is complete and no longer recruiting subjects.

Prostate Cancer

Progenics Pharmaceuticals, Inc.385 participantsStarted Nov 2016

San Francisco, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDNA< 1 mile

A Survivorship Care Plan and Embedded Navigation Tool

NCT03424837

This is a parallel group, multisite prospective clinical study. The purpose of this study is to evaluate whether ASCENT enables patients to adhere to the survivorship guidelines and improves coordination of care to address patient needs.

Prostate Cancer

Duke University77 participantsStarted Jan 2019

Tampa, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +3 more locations

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

A Survivorship Care Plan and Embedded Navigation Tool

Prostate Cancer Trials in Other Cities

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach

Ketogenic Diet and Prostate Cancer Surveillance Pilot

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Analyses of Human Samples Collected in Clinical Trials

Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS

Genetic Analysis of Hereditary Prostate Cancer

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Oral Calcitriol With Ketoconazole in CRPC

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Perioperative Post-Prostatectomy Incontinence Home Telehealth Program

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Other Conditions in Baltimore